Skip to content

The iBerry study *Interventions for Behavioral and Emotional Risk Reduction in Youth* Phase 2: Baseline datacollection on determinants of the transition from subclinical symptomatology to psychiatric disorders

The iBerry study *Interventions for Behavioral and Emotional Risk Reduction in Youth* Phase 2: Baseline datacollection on determinants of the transition from subclinical symptomatology to psychiatric disorders - The iBerry study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON46968
Enrollment
4050
Registered
2015-07-02
Start date
2015-08-19
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

(Child) psychiatric disorders

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
12 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Screenpositive or -negative based on the SDQ-Y score: a score within the highest 15% or a random sample from the lowest 85% - Age: 12 years or older - Written informed consent of (both) parents or legal caregivers - Written informed consent by the adolescent - Adolescent is able to speak and understand Dutch

Exclusion criteria

Exclusion criteria: Participation in the Generation R Study

Design outcomes

Primary

MeasureTime frame
Behavioral and emotional problems of youngsters Psychiatric disorders Lifestyle and substance use Family characteristics (parent-child interaction, conflict tactics, family coherence and communication style) Social support and bullying Sensation-seeking and impulsivity Genetics Epigenetics Hair cortisol Thyroid function Metabolic parameters Life events

Secondary

MeasureTime frame
Parental psychopathology Demographic characteristics Cognitive abilities Somatic symptoms Use of health care facilities

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)